Compare RGNX & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGNX | BFST |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.0M | 739.5M |
| IPO Year | 2015 | 2018 |
| Metric | RGNX | BFST |
|---|---|---|
| Price | $14.31 | $26.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $30.78 | $30.50 |
| AVG Volume (30 Days) | ★ 662.8K | 115.1K |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | N/A | ★ 11.95 |
| EPS | N/A | ★ 2.60 |
| Revenue | $161,318,000.00 | ★ $303,637,000.00 |
| Revenue This Year | $132.80 | $24.49 |
| Revenue Next Year | $45.32 | $17.08 |
| P/E Ratio | ★ N/A | $10.06 |
| Revenue Growth | ★ 91.30 | 21.51 |
| 52 Week Low | $5.04 | $20.07 |
| 52 Week High | $15.41 | $28.46 |
| Indicator | RGNX | BFST |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 41.63 |
| Support Level | $13.66 | $27.73 |
| Resistance Level | $15.41 | $26.99 |
| Average True Range (ATR) | 0.89 | 0.46 |
| MACD | -0.01 | -0.26 |
| Stochastic Oscillator | 60.66 | 4.08 |
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.